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Abstract: Oocytes are postulated to repress the proton pumps (e.g., complex IV) and ATP synthase 
to safeguard mitochondrial DNA homoplasmy by curtailing superoxide production. Whether the 
ATP synthase is inhibited is, however, unknown. Here we show that: oligomycin sensitive ATP 
synthase activity is significantly greater (~170 vs. 20 nmol/min–1/mg–1) in testes compared to oocytes 
in Xenopus laevis (X. laevis). Since ATP synthase activity is redox regulated, we explored a regulatory 
role for reversible thiol oxidation. If a protein thiol inhibits the ATP synthase, then constituent 
subunits must be reversibly oxidised. Catalyst-free trans-cyclooctene 6-methyltetrazine (TCO-Tz) 
immunocapture coupled to redox affinity blotting reveals several subunits in F1 (e.g., ATP-α-F1) and 
Fo (e.g., subunit c) are reversibly oxidised. Catalyst-free TCO-Tz Click PEGylation reveals significant 
(~60%) reversible ATP-α-F1 oxidation at two evolutionary conserved cysteine residues (C244 and C294) 
in oocytes. TCO-Tz Click PEGylation reveals ~20% of the total thiols in the ATP synthase are 
substantially oxidised. Chemically reversing thiol oxidation significantly increased oligomycin 
sensitive ATP synthase activity from ~12 to 100 nmol/min–1/mg–1 in oocytes. We conclude that 
reversible thiol oxidation inhibits the mitochondrial ATP synthase in X. laevis oocytes.  
Keywords: mitochondria; thiol; redox signaling; ATP synthase; oocyte; Xenopus laevis; click 
chemistry 
 
1. Introduction 
Human sperm rely on oxidative phosphorylation (OXPHOS) to swim 103 times their own length 
to fertilise an oocyte [1,2]. Paternal mitochondrial DNA (mtDNA) is purged and/or heavily diluted 
after fertilisation to ensure maternal inheritance dominates in the embryo [3,4]. Maternal inheritance 
avoids deleterious mtDNA heteroplasmy because OXPHOS sensitises sperm to oxidative DNA 
damage [5]. Oxidative DNA damage can occur when thermodynamically and kinetically competent 
reduced electron donors (e.g., prosthetic semiquinone radicals) catalyse the univalent reduction of 
ground state molecular dioxygen (O2) to superoxide [6,7]. Superoxide anion and its dismutation 
product hydrogen peroxide (H2O2) are chemically unable to oxidise DNA directly [8]. H2O2 can, 
however, react with DNA bound iron and copper ions to produce hydroxyl radical (OH•) [9–11]. In 
turn, OH• can damage pyrimidine and purine bases at a diffusion controlled rate (i.e., k ~ 109 M–1 s–1) 
via addition, oxidation, and abstraction reactions [12–14]. If OXPHOS imperils mtDNA homoplasmy, 
then oocyte mitochondria may repress it to curtail superoxide production.  
Allen [15] posits that: oocytes safeguard mtDNA homoplasmy by repressing OXPHOS to curtail 
superoxide production. In support, OXPHOS is repressed in oocytes compared to sperm in diverse 
phyla from jellyfish to mice [16–20]. Repressed OXPHOS is associated with lower mitochondrial free 
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radical levels in oocytes compared to sperm [16,17]. To curtail superoxide production by repressing 
OXPHOS without sacrificing oocyte viability, dual inhibition of the proton pumps (i.e., complex I, III 
and IV) and F1-Fo ATP synthase may be required. If the proton pumps are active and the F1-Fo ATP 
synthase is inactive, then a large electrochemical proton motive force (Δp) could substantially 
enhance superoxide production (e.g., by complex I catalysed reverse electron transfer [21]). 
Reciprocally, if the proton pumps are inactive and F1-Fo ATP synthase is active, then it may curtail 
complex I and III catalysed superoxide production, but the synthase may compromise oocyte 
viability by hydrolysing ATP to maintain Δp [22]. Whether the proton pumps and F1-Fo ATP synthase 
are inhibited in oocytes is, however, unknown. Unravelling if and how the F1-Fo ATP synthase is 
inhibited would advance current understanding of reproductive biology.  
Extant data imply the F1-Fo ATP synthase is inhibited in Xenopus laevis (X. laevis) oocytes. In 
support, the F1-Fo ATP synthase inhibitor oligomycin fails to deplete [ATP] in rapidly proliferating 
X. laevis blastulae [23,24]. Their oligomycin insensitivity may be explained by pre-existing inhibition 
by reversible thiol oxidation. Indeed, we observed substantial reversible thiol oxidation of the F1 
alpha subunit (ATP-α-F1) in X. laevis oocytes [25]. Informed by seminal work in chloroplasts and 
somatic mitochondria [26–33], we infer that the F1-Fo ATP synthase is inhibited by reversible thiol 
oxidation; which can tune protein function by modifying activity, subcellular locale, and/or vicinal 
interactome (reviewed in [34–38]). Since Yagi and Hatefi [26] first reported that reversible thiol 
oxidation inhibits the F1-Fo ATP synthase in 1984, subsequent studies [29,32,33] have shown that it 
regulates OXPHOS, superoxide production, and the mitochondrial permeability transition pore 
(reviewed in [31,39–41]). For example, Wang and colleagues [29] found that a disulfide bond between 
the ATP-α-F1 and gamma (ATP-γ-F1) subunits impaired OXPHOS in dyssynchronous heart failure.  
No study has investigated whether reversible thiol oxidation inhibits the F1-Fo ATP synthase in 
oocytes. To advance current understanding, we determined whether: (1) F1-Fo ATP synthase activity 
is impaired in the female germline compared to the testes (i.e., a somatic tissue responsible for 
producing the male germline); (2) the F1-Fo ATP synthase is assembled; (3) F1-Fo ATP synthase 
subunits are reversibly oxidised; and (4) F1-Fo ATP synthase activity is redox regulated in X. laevis 
oocytes. X. laevis oocytes are ideal because they are a tractable developmental model [42–44], 
insensitive to oligomycin [45,46], and key thiols are conserved [25].  
2. Materials and Methods 
2.1. Materials and Reagents 
A list of the materials and reagents used is provided (see Table S1).  
2.2. Xenopus laevis 
In-house bred X. laevis were maintained at the European Xenopus Resource Centre (EXRC) at 18 
°C and fed daily on trout pellets [47]. Following ethical approval (#OLETHSHE1500), X. laevis oocytes 
were harvested, defolliculated with collagenase, and stored at –80 °C for biochemical analysis. In line 
with the ARRIVE guidelines [48], biological variability was accounted for by obtaining samples from 
three different adult females.  
2.3. F1-Fo ATP Synthase Assay 
Mitochondria were isolated by differential centrifugation wherein oocytes (n = 10) were lysed in 
STE buffer (250 mM sucrose, 200 mM Tris-HCL, 2 mM EDTA, pH 7.2) supplemented with a protease 
inhibitor tablet, 1% fatty acid free BSA and 100 mM N-ethylmaleimide (NEM) to block reduced thiols 
for 10 min on ice. Lysates were centrifuged at 700× g for 10 min at 4 °C, before the supernatant was 
centrifuged at 7000× g for 10 min at 4 °C. After discarding the supernatant, the mitochondrial pellet 
was resuspended in STE with fresh 10 mM 1-4-Dithiothreitol (DTT) or without (control) for 30 min 
on ice. Mitochondria were pelleted and washed (3 × 1 min in BSA free STE) to remove excess DTT, 
before being treated with 50 µg/mL alamethicin to permeabilise the inner membrane to ATP [49], 1 
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µM diphenyleneiodonium to prevent complex I oxidising NADH by inhibiting the prosthetic flavin 
mononucleotide group, and 300 nM antimycin A to block complex III. In the reduced group, TCEP 
(2 mM) was used to maintain a reducing environment (e.g., prevent vicinal dithiols reforming 
disulfide bonds after reduction). TCEP is preferable to DTT for maintaining a reducing environment 
because DTT can autoxidise to produce superoxide in the presence of transition metals [12].  
F1-Fo ATP synthase activity was assessed by monitoring ATP hydrolysis in the presence of a 
glycolytic pyruvate kinase (PK), lactate dehydrogenase (LDH), and phosphoenolpyruvate (PEP) 
system to regenerate ATP. ATP hydrolysis was followed as the decrease in NADH absorbance at 340 
nm (extinction coefficient: 6.22 Mm–1 cm–1) using a plate reader. Mitochondria were analysed in 
duplicate in a reaction buffer containing (400 µM NADH, 1 mM PEP, 20 U/mL LDH, 15 U/mL PK, 
and 2.5 mM ATP in 200 mM Tris, 2 mM MgCl2, 200 µM EDTA, pH 8.0). ATP hydrolysis was followed 
for 2 min without mitochondria to account for spontaneous ATP hydrolysis. Mitochondria were 
added and NADH absorbance was monitored for every 15 s 10 min. All wells were then spiked with 
6 µM oligomycin and NADH absorbance was followed for 5 min to determine specific F1-Fo ATP 
synthase activity. After determining protein content using a Bradford assay and subtracting 
oligomycin insensitive absorbance, F1-Fo ATP synthase activity (nmol/min–1/mg–1) was calculated 
using the following equation: (Δ 340/min × 1000)/[(extinction coefficient × sample volume) × protein 
concentration)] [50]. 
2.4. Native Blotting 
Mitochondrial membranes were solubilised with 5 µL of 20% dodecyl lauryl maltoside (DDM) 
in PBS. After centrifuging samples at 16,250× g for 12 min at 4 °C, 0.1% Ponceau S was added to the 
supernatant to establish a dye front [51]. High resolution clear native polyacrylamide gel 
electrophoresis (Hr-CNPAGE) was performed as described by Wittig and colleagues [51] using a 
cathode (50 mM Tricine, 7.5 mM Imidazole, 0.02% DDM, and 0.05% sodium deoxycholate, pH ~7) 
and anode buffer (25 mM Imidazole, pH ~7). Electrophoresis was performed at 4 °C for 90 min to 
prevent band broadening and to ensure sufficient protein transfer [52]. Gels were transferred onto a 
low autofluorescence 0.45 µM polyvinylidene fluoride (PVDF) membrane at 100 V for 60 min in 
transfer buffer (50 mM Tricine, 7.5 mM Imidazole, pH 7) at 4 °C. Membranes were blocked with 5% 
non-fat dry milk (NFDM) in PBS for at least 60 min. Primary/secondary antibody incubations and 
fluorescent detection are described below (see Redox Mobility Shift Assay).  
2.5. In-Gel ATP Hydrolysis Assay 
Mitochondrial membranes were solubilised with DDM and Hr-CNPAGE was performed as 
described above. After alkylating reduced thiols with NEM (100 mM), reversibly oxidised thiols were 
treated with (reduced) or without (control) 3.5 mM TCEP for 15 min. Oligomycin controls (500 nM) 
were loaded in parallel. An equal amount of protein (5 µg) was loaded onto a precast 4–15% gradient 
gel. Native gels were incubated with buffer (35 mM Tris, 270 mM Glycine, pH 8.3) for 2 h, before 
being incubated with assay buffer (35 mM Tris, 270 mM Glycine, 14 mM MgSO4, 0.2% Pb(NO3)2, 
2.8mM ATP, pH 8.3) for 2 h at room temperature. The reaction was stopped with 50% methanol for 
30 min before membranes were scanned. Images were inverted to visualise the white bands and 
densitometry was performed using VisionWorksTM software (Analytik Jena, Germany). 
2.6. Catalyst-Free TCO-Tz Immunocapture Coupled to Redox Affinity Blotting 
Aliquots (5 µL) of anti-ATP-α-F1 primary antibody were incubated with 10 mM trans-
cyclooctene polyethylene glycol 4 (PEG) N-hydroxysuccinimide (TCO-PEG4-NHS) for 30 min at 4 °C 
to label primary amines. To prevent unwanted labelling of primary amines in the sample, excess 
TCO-PEG4-NHS was quenched by adding 5 mM Tris for 15 min. A 45 min total reaction time should 
ensure NHS hydrolysis outcompetes the carbodiimide reaction thereby preventing adventitious 
sample labelling. Mitochondrial membranes were prepared as described below (see Catalyst-free 
TCO-Tz Click PEGylation), except TCO-PEG3-maleimide (TCO-PEG3-NEM) was substituted for 5 
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mM Biotin-dPEG®3-maleimide (Sigma, UK, Biotin-dPEG®3-MAL). Biotin-dPEG®3-MAL labelled 
mitochondrial membranes were incubated with TCO-PEG4-NHS labelled primary antibody for 30 
min on ice, before being placed in a spin cup containing 85 µL 6-methyltetrazine substituted agarose 
beads to initiate the catalyst-free Inverse Electron Demand Diels Alder (IEDDA) Click reaction for 90 
min on ice. Clicked samples were washed in PBS supplemented with 0.05% DDM for 1 min before 
being centrifuged for 1 min at 1000× g (washing was repeated five times). Using a spin cup increases 
purity by removing contaminants with high stringency. Western blotting was performed as described 
below (see Redox Mobility Shift Assay), expect Streptavidin Alexa Fluor™ 647 (ThermoFisher, UK, 
1:500 in TBST for 60 min at room temperature) was used to detect reversibly oxidised subunits on an 
Analytik Jena (Analytik Jena, Germany) scanner using the appropriate filters (excitation: 600–645 nm; 
emission: 607–682 nm).  
2.7. Catalyst-Free TCO-Tz Click PEGylation  
We amended whole-cell TCO-Tz Click PEGylation for mitochondria [25]. Oocytes (n = 10) were 
lysed in STE buffer supplemented with a protease inhibitor tablet, 1% fatty acid free BSA and 100 
mM NEM) to block reduced thiols for 10 min on ice. Lysates were centrifuged at 700× g for 10 min at 
4 °C, before the supernatant was centrifuged at 7000× g for 10 min at 4 °C. Mitochondrial pellets were 
resuspended in STE with 5 mM TCEP for 30 min on ice. After washing to remove excess TCEP, 
mitochondria were resuspended in 5 mM TCO-PEG3-NEM to label newly reduced thiols [36]. 
Alamethicin (50 µg/mL) was added to ensure TCO-PEG3-NEM could permeate the inner 
mitochondrial membrane. Mitochondria were lysed in PBS (pH 7.3) supplemented with 1.5% (v/v) 
20% DDM. After removing insoluble material by centrifugation (14,000× g for 5 min at 4 °C), the 
supernatant was incubated with 5 mM 6-methyltetrazine 5 kDa PEG (Tz-PEG5) for 90 min on ice. The 
catalyst-free IEDDA Click reaction was terminated by adding Laemmli buffer (4% SDS, 20% Glycerol, 
0.004% Bromophenol blue and 125 mM Tris HCl, pH 6.8) supplemented with 100 mM DTT before 
samples were denatured at 80 °C for 5 min.  
2.8. Redox Mobility Shift Assay 
The Redox Mobility Shift Assay and analysis were performed as described in [25]. After 
following a standard Western blot protocol [53,54], PVDF membranes were incubated with anti-ATP-
α-F1 primary antibody (1 µg/mL in 3% NFDM TBST) overnight. Washed and incubated with a 
preabsorbed Alexa Fluor®750 secondary antibody (Abcam, UK, 1:2000 in 3% NDFM TBST). 
Membranes were imaged (excitation: 678–748 nm; emission: 767–807 nm) on an Analytik Jena scanner 
(Germany).  
2.9. Statistical Analysis 
Oligomycin sensitive F1-Fo ATP synthase activity data were analysed using independent 
Student’s t-tests with alpha ≤ 0.05. TCO-Tz Click PEGylation data were analysed by paired Student’s 
t-tests with alpha ≤ 0.05. Statistical analysis was performed on GraphPad Prism (GraphPad Software, 
USA). Data are presented as Mean and standard deviation (±). 
3. Results 
3.1. F1-Fo ATP Synthase Activity is Significantly Greater in Testes Compared to Oocytes  
Allen [15] proposes that: oocytes repress OXPHOS to safeguard mtDNA homoplasmy by 
curtailing superoxide production. If so, F1-Fo ATP synthase activity should be greater in the soma 
compared to the female germline. Sperm, a major cell type in testes, should sacrifice mtDNA 
homoplasmy by practicing OXPHOS [15]. Isolating sperm without contaminating somatic tissue (i.e., 
sertoli cells) is problematic; a situation abetted by a five orders of magnitude difference in 
mitochondrial number between sperm (102) and oocytes (107) in X. laevis [55]. Accordingly, we 
assessed mitochondrial F1-Fo ATP synthase activity in oocytes compared to testes. We measured ATP 
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hydrolysis using a glycolytic ATP regenerating system in isolated mitochondria treated with 
alamethicin [49] (Figure 1A). Using alamethicin to render the inner mitochondrial membrane 
permeable to ATP placed the rate-limiting step on the F1-Fo ATP synthase by eliminating the influence 
of the proton pumps and ATP/ADP carrier [22]. Oligomycin sensitive F1-Fo ATP synthase activity is 
significantly (p ≤ 0.0001) lower in oocytes compared to testes (oocyte: 18.81 ± 15.38; testes: 177.1 ± 
37.82 nmol/min–1/mg–1; Figure 1B).  
 
Figure 1. Oligomycin sensitive F1-Fo ATP synthase activity is significantly greater in testes compared 
to oocytes. (A) The F1-Fo ATP synthase hydrolysis ATP to ADP. Pyruvate kinase regenerates ATP by 
using phosphoenolpyruvate (PEP) to phosphorylate ADP to ATP. Lactate dehydrogenase reduces 
pyruvate to lactate using NADH derived electrons. F1-Fo ATP synthase activity is followed by 
monitoring the loss of NADH absorbance at 340 nm. (B). Oligomycin sensitive F1-Fo ATP synthase 
activity is higher significantly (p ≤ 0.0001) in testes (n = 6) compared to oocytes (n = 6) in X. laevis. 
Statistical significance is indicated by an asterix as assessed by an independent Student’s t-test. (C). 
Native ATP-α-F1 blot image showing the F1-Fo ATP synthase is fully assembled in X. laevis oocytes (n 
= 4). A minor fraction is present as an F1 subcomplex. Each n is the weighted mean of 10 oocytes. 
3.2. The F1-Fo ATP Synthase is Assembled in Oocytes 
Sieber and colleagues [45] identified a Coomassie stained band on a native gel that may 
correspond to assembled F1-Fo ATP synthase in X. laevis oocytes. To immunologically confirm F1-Fo 
ATP synthase assembly, we performed a native blot against the ATP-α-F1 subunit [51,52]. Native 
blotting reveals the F1-Fo ATP synthase is assembled in X. laevis oocytes (Figure 1C). F1-Fo ATP 
synthase disassembly is, therefore, unlikely to explain low oligomycin sensitive ATP hydrolysis in 
oocytes. Low activity is also unlikely to be attributable to low abundance because ATP-β-F1 content 
is estimated to be 7.1 µM in X. laevis oocytes [56]. F1-Fo ATP synthase assembly and abundance implies 
latent enzyme capacity that may be realised by reversing inhibitory thiol oxidation.  
3.3. Several F1-Fo ATP Synthase Subunits are Reversibly Oxidised  
If reversible thiol oxidation is inhibitory, then F1-Fo ATP synthase subunits must be reversibly 
oxidised. Annotated genome data reveals the F1-Fo ATP synthase contains 18 thiols in X. laevis [42] 
(see Table 1). After excluding mitochondrial leader sequences, the F1-Fo ATP synthase likely contains 
10–11 thiols depending on whether the L or S chromosome copy of ATP-y-F1 is expressed. Available 
structures suggest cysteine residues in ATP-α-F1 (C244, C294), ATP-γ-F1 (C100, C173), OSCP (C139), and 
subunit c (C149) are likely fully and/or partially solvent exposed in catalytic state 3A [57] (Figure 2). 
Assuming a similar structure in X. laevis, C104 in subunit b may also be solvent exposed. To determine 
whether F1-Fo ATP synthase subunits are reversibly oxidised, we used a catalyst-free TCO-Tz 
immunocapture approach coupled to redox affinity blotting (Figure 3A). Since the ATP-α-F1 antibody 
recognises the assembled complex, we used a heterobifunctional TCO-PEG4-NHS linker to form a 
stable carbodiimide bond with primary amines in the ATP-α-F1 antibody. After labelling reversibly 
oxidised samples with Biotin-dPEG®3-MAL, samples were incubated with TCO-PEG4-NHS labelled 
ATP-α-F1 antibody before 6-methyltetrazine substituted agarose was used to capture the synthase. 
Reversibly oxidised F1-Fo ATP synthase subunits were detected by Western blot using a streptavidin 
conjugated fluorophore [36]. 
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Figure 2. Cysteine residues in bovine Fo-F1 ATP synthase in catalytic state 3A. Numbered cysteine 
residues are highlighted in yellow. The key lists the cysteine residue by amino acid number for the 
bovine enzyme with the equivalent X. laevis residue in brackets in bold. A coloured asterix denotes 
the predicted position of additional cysteine residues in X. laevis. Additional cysteine residues are 
highlighted in bold in the key if they are likely to be solvent exposed. No structural data is available 
for subunit g and C3. 
Table 1. Cysteine residues in F1-Fo ATP synthase in X. laevis. No annotated information could be 
found for ATP synthase subunit epsilon (ATP-ε-F1), subunit DAPIT, ATP synthase F(0) complex 
subunit C2, and ATP synthase subunit e (subunit e). 
ATP Synthase Subunit Uniprot ID Domain 
Molecular 
Weight (kDa) 
Cysteine 
Residues 
Subunit a P00849 Fo 25 None 
Subunit ACL P03931 Fo 6.5 None 
C domain-containing protein 
(subunit c) 
A0A1L8HIH0 Fo 16.9 
34*, 49*, 84, 
149 
Coupling factor 6 Q6PG55 Fo 12.3 None 
Subunit C3 (subunit c3) Q8AVE1 Fo 14.7 4*, 131 
Subunit f A0A1L8EX92 Fo 10.4 None 
Subunit g (subunit g) Q66L24 Fo 11 96 
Subunit alpha (ATP-α-F1) Q68EY5 F1 60 244, 294 
Subunit beta (ATP-β-F1) A0A1L8HHY6 F1 56.4 9*@, 20*, 31* 
Subunit gamma (ATP-γ-F1) Q6INB6 F1 32.4 100, 173# 
Subunit delta (ATP-δ-F1) Q66KY9 F1 16.9 None 
Oligomycin sensitivity conferring 
protein (OSCP) 
Q3KQC0 F1 22.8 139 
Subunit b (subunit b) Q9IAJ7 F1 28.2 26*, 104, 235 
*Likely in the mitochondrial leader sequence; @Only present on the L chromosome copy of the 
protein; #Only present on the S chromosome copy of the protein. 
Catalyst-free TCO-Tz immunocapture coupled to redox affinity blotting reveals discrete bands 
at ~100, 50, 37, 30, 20–25, and ≤ 10 kDa. Additionally, a distorted band at ~10 kDa was observed, which 
may reflect how DDM and SDS interact with hydrophobic proteins. Based on a theoretical profile 
constructed from Table 1 (Figure 3B), observed bands likely correspond to ATP-α-F1, ATP-γ-F1, 
OSCP, subunit b and g (Figure 3C). For OSCP and subunit g, the observed band reflects reversible 
C139 and C96 oxidation, respectively, because they contain a single thiol. After excluding mitochondrial 
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leader sequences, the distorted band is likely an Fo subunit (e.g., subunit c and/or C3). The unassigned 
~100 kDa band may represent an interacting protein, hydrophobic aggregate (likely heat induced), 
and/or crosslinked subunits. Proteomic profiling of the captured complex will be reported elsewhere. 
F1-Fo ATP synthase subunits are reversibly oxidised in oocytes.  
 
Figure 3. Several F1-Fo ATP synthase subunits are reversibly oxidised. (A). Catalyst-free trans-
cyclooctene-6methyltetrazine (TCO-Tz) immunocapture coupled to redox affinity blotting workflow. 
From left to right: Primary amines in the ATP-α-F1 antibody are labelled with a heterobifunctional 
NHS-PEG4-TCO linker. After excess NHS is quenched with Tris (not shown), the labelled antibody 
is incubated with Biotin functionalised maleimide labelled reversibly oxidised thiols in mitochondrial 
membranes to capture the F1-Fo ATP synthase. Agarose beads substituted with 6-methyltetrazine are 
then used to selectively capture the antibody-synthase complex. After washing away contaminants 
with a spin cup, samples are boiled, denatured, and reduced to elute subunits for streptavidin 
blotting. Streptavidin, conjugated Alexa Fluor™ 647 positive bands denote reversibly oxidised 
subunits. (B). A predicted reversibly oxidised subunit profile based on Table 1. (C). Representative 
image of an experimentally observed reversibly oxidised subunit profile alongside a molecular 
weight (MW) ladder. Arrows indicate the predicted identity of the observed bands. The image shows 
several F1-Fo ATP synthase subunits are reversibly oxidised. An unpredicted band at 100 kDa was 
observed (see main text). Clickable TCO-Tz immunocapture coupled to redox affinity blotting was 
performed on five pools of 10 X. laevis oocytes. Each lane represents the weighted mean of 10 oocytes. 
3.4. Reversible ATP-α-F1 Oxidation is Significant in Oocytes  
After demonstrating that F1-Fo ATP synthase subunits are reversibly oxidised, we 
immunologically verified an observed band. To do so, we assessed whether ATP-α-F1 is reversibly 
oxidised at two evolutionary conserved cysteine residues (C244 and C294) using catalyst-free TCO-Tz 
Click PEGylation [25]. TCO-Tz Click PEGylation exploits catalyst-free IEDDA chemistry [58–60] to 
selectively conjugate a low molecular weight (5 kDa) PEG moiety to reversibly oxidised thiols. 
Selectively conjugating PEG imparts an electrophoretic mobility shift to render reversibly oxidised 
thiols detectable as mass shifted bands by Western blotting [25,61,62] (Figure 4A). Consistent with 
our previous work [25], TCO-Tz Click PEGylation reveals that: 62.9 ± 3.0% of total ATP-α-F1 is 
reversibly oxidised in oocytes (Figure 4B). Percent reversibly oxidised ATP-α-F1 is significantly (p = 
0.0007) greater than the amount of reduced ATP-α-F1 (Figure 4C). No significant difference (p = 
0.9611) in the contribution of the 5 (49.8 ± 10.4%) and 10 (50.2 ± 10.4%) kDa bands to total percent 
reversibly oxidised ATP-α-F1 was observed (Figure 4D). TCO-Tz Click PEGylation reveals ~20% (2 
out of 10 or 11) of the total thiols in the F1-Fo ATP synthase are substantially oxidised.  
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Figure 4. Reversible ATP-α-F1 oxidation is significant in oocytes. (A). Catalyst-free trans-cyclooctene-
6methyltetrazine (TCO-Tz) Click PEGylation scheme for reversibly oxidised thiols. Left to right: 
Reduced thiols are alkylated with NEM. Reversibly oxidised thiols are reduced with TCEP before 
being alkylated with TCO-PEG3-NEM (TPN). TPN labelled thiols are incubated with Tz-PEG5 to 
initiate the catalyst-free IEDDA Click reaction. Reversibly oxidised thiols are then mass shifted when 
assessed by Western Blot owing to a PEG induced electrophoretic mobility shift. (B). Western blot 
image showing reversibly oxidised (i.e., mass shifted 5 and 10 kDa bands) relative to reduced ATP-
α-F1 (i.e., lower band) in X. laevis oocytes (n = 5). MW = molecular weight. (C). Percent reversibly 
oxidised (i.e., mass shifted) compared to reduced (unshifted) ATP-α-F1 quantified. Percent reversibly 
oxidised ATP-α-F1 is significantly (p = 0.0007) greater than the amount of reduced ATP-α-F1. An 
asterix denotes statistical significance as assessed by a paired Student’s t-test. (D). Quantified 
percentage contribution of the 5 and 10 kDa bands to the total mass shifted (i.e., reversibly oxidised) 
signal. No significant difference (p = 0.09611) in the contribution of the 5 and 10 kDa band signal was 
observed as assessed by a paired Student’s t-test. Each n is the weighted mean of 10 oocytes. 
3.5. Reversible Thiol Oxidation Inhibits the F1-Fo ATP Synthase  
Having established several subunits are reversibly oxidised, we explored whether F1-Fo ATP 
synthase activity is redox regulated. If reversible thiol oxidation inhibits the F1-Fo ATP synthase, then 
chemically reducing oxidised thiols using TCEP should increase F1-Fo ATP synthase activity in 
oocytes. TCEP significantly (p = 0.0007) increases oligomycin sensitive F1-Fo ATP synthase activity in 
oocytes (TCEP: 102.9 ± 44.97; Control: 12.90 ± 7.3 nmol/min–1/mg–1; Figure 5A). Alkylating reduced 
thiols with 5 mM NEM means ex vivo thiol oxidation is unlikely to constrain F1-Fo ATP synthase 
activity in the control. Previous work excluded the possibility that: 5 mM NEM inhibits F1-Fo ATP 
synthase activity [29]. To be sure, we assessed F1-Fo ATP synthase catalysed ATP hydrolysis using 
Hr-CNPAGE [51]. In this assay, F1-Fo ATP synthase catalysed ATP hydrolysis is detected as white 
lead phosphate precipitates (Figure 5B). TCEP significantly increased (p = 0.0067) F1-Fo ATP synthase 
mediated ATP hydrolysis in oocytes (TCEP: 111.8 ± 10.0; Control: 75.0 ± 7.2; Figure 5C).  
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Figure 5. Reversible thiol oxidation inhibits the F1-Fo ATP synthase. (A). Chemically reversing thiol 
oxidation using TCEP substantially increases F1-Fo ATP synthase activity. Specifically, oligomycin 
sensitive F1-Fo ATP synthase activity is significantly greater (p = 0.0007) in TCEP (n = 6) compared to 
control oocytes (n = 6) in X. laevis. (B). Inverted Hr-CNPAGE image of F1-Fo ATP synthase mediated 
in-gel ATP hydrolysis. No signal is observed in oligomycin treated controls and a decreased signal in 
the TCEP condition. (C). Densitometry based quantification reveals a significant (p = 0.0067) increased 
F1-Fo ATP synthase mediated ATP hydrolysis in TCEP (n = 3) compared to control oocytes (n = 3) in 
X. laevis. Statistical significance is indicated by an asterix as assed by an independent Student’s t-test. 
Each n is the weighted mean of 10 oocytes. 
4. Discussion 
We advance knowledge of reproductive biology by showing, for the first time, that the F1-Fo ATP 
synthase is inhibited in X. laevis oocytes. Repressed F1-Fo ATP synthase activity could impair 
OXPHOS by uncoupling Δp from ATP synthesis, but may enhance oocyte viability by constraining 
ATP hydrolysis. In considering Allen’s theory [15], low F1-Fo ATP synthase activity would curtail 
superoxide production to safeguard mtDNA homoplasmy provided the proton pumps were 
inhibited. In support, cytochrome c oxidase (i.e., complex IV) activity is repressed and H2O2 levels 
are low in X. laevis oocytes [23,46]. Complete proton pump inhibition is, however, unlikely because 
oocyte mitochondria sustain an Δp and still produce some superoxide [23,63]. Protein binding to 
shield mtDNA and/or selectively curtailing superoxide production at single site (e.g., complex I) may, 
therefore, be required to safeguard mtDNA homoplasmy. Follow-up studies are required to 
determine proton pump activity and superoxide production in X. laevis oocytes using state-of-the-art 
tools (e.g., MitoNeoD [64]).  
Existing literature has firmly established that F1-Fo ATP synthase activity is redox regulated in 
somatic mitochondria [26–33]. Current understanding is, however, restricted to isolated organelles 
and/or disease models. Whether redox regulation plays a physiological role is, therefore, unclear. We 
make a major novel contribution by showing that: chemically reversing protein thiol oxidation 
significantly increases F1-Fo ATP synthase activity in X. laevis oocytes. Our result defines a novel 
physiological role for mitochondrial reversible thiol oxidation in reproductive biology. Using a redox 
switch to inactivate the synthase during oogenesis would only imperil mtDNA homoplasmy if any 
damage sustained was unrepaired. Importantly, cells can transduce redox signals without sustaining 
oxidative macromolecule damage [65]. The ability of a redox switch to hold the F1-Fo ATP synthase 
inactive informs several hypotheses. For example, a protein thiol could regulate the metabolic switch 
from a reliance on fermenting glucose to OXPHOS in the developing X. laevis retina [66]. If a such a 
developmental Warburg phenotype is redox regulated, it may help rationalise how mitochondrial 
oxidative stress rewires metabolism in cancer [67].  
Unravelling how reversible thiol oxidation inhibits the F1-Fo ATP synthase in oocytes relies on 
using redox proteomics and site-directed mutagenesis to identify the redox switch(es) (i.e., subunit 
(s) and site (s)) [68–70]. Disambiguating reversible modification type is also important because S-
glutathionylation and disulfide bonds may inhibit the enzyme by different mechanisms [39]. 
Biological precedent exists: ATP-α-F1 S-glutathionylation seems to electrostatically repel nucleotide 
binding by introducing a bulky negative charge whereas intermolecular disulfide bonds between 
ATP-α-F1 and ATP-γ-F1 may impair conformational flexibility [30]. Reversible thiol oxidation in Fo is 
likely to inhibit catalysis by disrupting the ability to bind protons and/or rotate the c-ring [31,39–
41,71]. For example, reversible oxidation of subunit c at C84 could impede proton transport owing to 
its proximity to glutamate 58 [72,73]. Reversible thiol oxidation may also protect the F1-Fo ATP 
synthase from irreversible inactivation secondary to sulfinic and sulfonic acid formation [25]. If 
reversible thiol oxidation impacts inhibitor binding and/or action, then it may lead to oligomycin 
sensitive enzyme activity being underreported. Given reversible thiol oxidation can activate several 
enzymes, it is unwise to assume reversible thiol oxidation is always inhibitory. Intriguingly, a redox 
code may exist wherein the biological outcome varies according to the number of thiols and subunits 
modified, occupancy (percent oxidation), and modification type [65].  
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From a structural perspective, S-glutathionylation could lock the F1-Fo ATP synthase in a 
monomeric state by impeding the formation of dimers, especially if they involve intermolecular 
disulfide bonds [31]. Alternatively, a negative charge may electrostatically repel dimer interfaces. 
Thiols in subunit e and g also regulate the stability and formation of oligomers, which dictate inner 
mitochondrial membrane topology [74–76]. For example, F1-Fo ATP synthase dimers shape cristae to 
create an efficient proton sink for ATP synthesis [77]. Perhaps, Fo redox state underlies the lack of 
mature cristae in oocytes [19]. Teixeira and colleagues [78] found that OXPHOS is dispensable for 
germline stem cell differentiation but F1-Fo ATP synthase dimers are essential because they are 
required for cristae maturation. The results of their study and the present work raise the possibility 
of at least two redox switches: (1) to prohibit dimers; and (2) to inhibit catalysis. Two redox switches 
would endow mitochondria with the capacity to differentiate cristae without a catalytically active F1-
Fo ATP synthase. That is, to uncouple cristae differentiation from OXPHOS [78].  
5. Conclusions 
We conclude that: (1) F1-Fo ATP synthase activity is significantly greater in testes compared to 
oocytes; (2) F1-Fo ATP synthase subunits are reversibly oxidised in oocytes; (3) reversible ATP-α-F1 
oxidation at evolutionary conserved cysteine residues (C244 and C294) is substantial (~60% of total ATP-
α-F1) in oocytes; and (4) chemically reversing thiol oxidation significantly increases F1-Fo ATP 
synthase activity. Reversible thiol oxidation, therefore, inhibits the mitochondrial ATP synthase in X. 
laevis oocytes.  
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